Jing Liang

Jing Liang

Auto-generated profile, based on publicly available information

Jing Liang

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Molecular Cell
Verified
Journal Article
Closed access
SLShumeng Liu
Shumeng Liu
HYHuajing Yu
Huajing Yu
YLYongqing Liu
Yongqing Liu
XLXinhua Liu
Xinhua Liu
YZYu Zhang
Yu Zhang
YSYongfeng Shang
Yongfeng Shang

26 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
FZFang Zheng
Fang Zheng
JCJianing Chen
Jianing Chen
XZXiaoqian Zhang
Xiaoqian Zhang
ZWZifeng Wang
Zifeng Wang
JCJiewen Chen
Jiewen Chen
ESErwei Song
Erwei Song
Hypoxia-inducible factor-1 (HIF-1) is a master driver of glucose metabolism in cancer cells. Here, we demonstrate that a HIF-1α anti-sense lncRNA, HIFAL, is essential for maintaining and enhancing HIF-1α-mediated transactivation and glycolysis. Mechanistically, HIFAL recruits prolyl hydroxylase 3 (PHD3) to pyruvate kinase 2 (PKM2) to induce its prolyl hydroxylation and introduces the PKM2/PHD3 complex into the nucleus via binding with heterogeneous nuclear ribonucleoprotein F (hnRNPF) to enhance HIF-1α transactivation. Reciprocally, HIF-1α induces HIFAL transcription, which forms a positive feed-forward loop to maintain the transactivation activity of HIF-1α. Clinically, high HIFAL expression is associated with aggressive breast cancer phenotype and poor patient outcome. Furthermore, HIFAL overexpression promotes tumor growth in vivo, while targeting both HIFAL and HIF-1α significantly reduces their effect on cancer growth. Overall, our results indicate a critical regulatory role of HIFAL in HIF-1α-driven transactivation and glycolysis, identifying HIFAL as a therapeutic target for cancer treatment.

13 March 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
HYHuajing Yu
Huajing Yu
CBChen Bu
Chen Bu
YLYuncheng Liu
Yuncheng Liu
TGTianyu Gong
Tianyu Gong
XLXiaoping Liu
Xiaoping Liu
JLJing Liang
Jing Liang
Large-scale crotonylome reveals CDYL-regulated crotonylation in diverse functions including RPA-mediated HR DNA repair.

12 April 2021 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
JLJiang Liu
Jiang Liu
LLLiyan Lao
Liyan Lao
JCJianing Chen
Jianing Chen
WZWenfeng Zeng
Wenfeng Zeng
XZXiaofeng Zhu
Xiaofeng Zhu
ESErwei Song
Erwei Song

28 April 2017 in Journal of Molecular Cell Biology
Verified
Journal Article
Open access
PDF file
YLYongqing Liu
Yongqing Liu
SLShumeng Liu
Shumeng Liu
SYShuai Yuan
Shuai Yuan
HYHuajing Yu
Huajing Yu
YZYu Zhang
Yu Zhang
JLJing Liang
Jing Liang
Faithful transmission or restoration of epigenetic information such as repressive histone modifications through generations is critical for the maintenance of cell identity. We report here that chromodomain Y-like protein (CDYL), a chromodomain-containing transcription corepressor, is physically associated with chromatin assembly factor 1 (CAF-1) and the replicative helicase MCM complex. We showed that CDYL bridges CAF-1 and MCM, facilitating histone transfer and deposition during DNA replication. We demonstrated that CDYL recruits histone-modifying enzymes G9a, SETDB1, and EZH2 to replication forks, leading to the addition of H3K9me2/3 and H3K27me2/3 on newly deposited histone H3. Significantly, depletion of CDYL impedes early S phase progression and sensitizes cells to DNA damage. Our data indicate that CDYL plays an important role in the transmission/restoration of repressive histone marks, thereby preserving the epigenetic landscape for the maintenance of cell identity.

1 September 2022 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
LDLin Dang
Lin Dang
XCXinyi Cao
Xinyi Cao
TZTianye Zhang
Tianye Zhang
YSYongzhan Sun
Yongzhan Sun
STShanshan Tian
Shanshan Tian
YCYupeng Chen
Yupeng Chen
Background: Emerging evidence indicates that epigenetic modulation of gene expression plays a key role in the progression of autosomal dominant polycystic kidney disease (ADPKD). However, the molecular basis for how the altered epigenome modulates transcriptional responses, and thereby disease progression in ADPKD, remains largely unknown. Methods: Kidneys from control and ADPKD mice were examined for the expression of CDYL and histone acylations. CDYL expression and its correlation with disease severity were analyzed in a cohort of patients with ADPKD. Cdyl transgenic mice were crossed with Pkd1 knockout mice to explore CDYL’s role in ADPKD progression. Integrated cistromic and transcriptomic analyses were performed to identify direct CDYL target genes. High-sensitivity mass spectrometry analyses were undertaken to characterize CDYL-regulated histone lysine crotonylations (Kcr). Biochemical analysis and zebrafish models were used for investigating CDYL phase separation. Results: CDYL was downregulated in ADPKD kidneys, accompanied by an increase of histone Kcr. Genetic overexpression of Cdyl reduced histone Kcr and slowed cyst growth. We identified CDYL-regulated cyst-associated genes, whose downregulation depended on CDYL-mediated suppression of histone Kcr. CDYL assembled nuclear condensates through liquid-liquid phase separation in cultured kidney epithelial cells and in normal kidney tissues. The phase-separating capacity of CDYL was required for efficient suppression of locus-specific histone Kcr, of expression of its target genes, and of cyst growth. Conclusions: These results elucidate a mechanism by which CDYL nuclear condensation links histone Kcr to transcriptional responses and cystogenesis in ADPKD.